Evaluates predictive toxicity models for PFAS disrupting transthyretin function, indicating implications for toxicokinetic assessments.
levels, supporting the AOP. The development of reliable predictive toxicity models for PFAS requires extensive validation, maximal use of available experimental data, and careful consideration of toxicokinetic differences in interchemical comparisons.
No takes yet. Share an insight, caveat, or question.
Almeida et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: